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416a Tuesday, March 8, 2011Consequently, we investigate the role of kinases/phosphatases and cytoskeleton
modulators (colchicine and cytochalasin D) on RyR-mediated Ca2þ leak from
SR microsomes as well as on coupled RyR1. We also investigated role of
FKBP12 in coupled RyR1 gating by adding FKBP12 to partially coupled
RyR1 or rapamycin to coupled RyR1 in planar lipid bilayers. Our results sug-
gest the RyR1-RyR1 interactions that are essential for coupled gating were not
significantly affected by addition of kinases/phosphatases, cytoskeleton modu-
lators or the addition/removal of FKBP12 by rapamycin. Yet, some of the
agents affected the overall activity of the RyR1. (Supported by NIH R01
GM078665).
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CGP37157 is an Inhibitor of the Sarcoplasmic Reticulum Calcium ATPase
and an Activator of Ryanodine Receptors in Striated Muscle
Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer,
Julio A. Copello.
CGP-37157 (CGP), a benzothiazepine derivative of clonazepam, is commonly
utilized as a blocker of the mitochondrial Naþ/Ca2þ exchanger. Yet, evidence
suggests that CGP could also affect other targets, such as L-type Ca2þ chan-
nels and plasmalemma Naþ/Ca2þ exchanger. Here, we tested the possibility of
a direct modulation of ryanodine receptors (RyR) and/or sarcoplasmic reticu-
lum (SR) Ca2þ stimulated ATPase (SERCA) by CGP. SERCA activity was
measured in SR microsomes with a ATP-ase activity assay or Ca2þ loading
in presence of ruthenium red (RyR blocker). The effects of CGP on RyR ac-
tivity were performed in SR microsomes with a Ca2þ leak assay or after re-
constitution of the channels into planar lipid bilayers. CGP inhibited
SERCA-mediated Ca2þ uptake of cardiac and skeletal SR microsomes
(IC50’s = 6.6 and 9.9 mM, respectively). The CGP effects on SERCA activity
correlated with a decreased Vmax of ATPase activity of SERCA-enriched skel-
etal SR fractions without an apparent change in Km. CGP (R 5 mM) also in-
creased RyR-mediated Ca2þ leak from skeletal SR microsomes. Planar bilayer
studies confirmed that both cardiac and skeletal RyR are directly activated by
CGP (EC50’s = 9.4 and 12.0 mM, respectively). In summary, we found that
CPG inhibits SERCA and activates RyR channels. Hence, the action of
CGP on cellular Ca2þ homeostasis reported in the literature of cardiac, skel-
etal muscle as well as other non muscle systems requires further analysis to
take into account the contribution of all CGP-sensitive Ca2þ transporters.
(Supported by NIH R01 GM078665).
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Tetracaine is a Potent Inhibitor of SR Ca Leak in Ventricular Cardiac
Myocytes
Stephen Shonts.
Tetracaine is commonly used to inhibit RyR-dependent SR Ca leak, however
ability to do so in intact cardiac myocytes has not been fully characterized.
In single RyR channel bilayer a significant portion of leak would not be in-
hibited even by low millimolar concentrations of tetracaine. In this study we
investigated the effectiveness of tetracaine on RYR-dependent SR Ca leak in
ventricular myocytes. Experiments were performed in isolated rabbit myo-
cytes loaded with fluo-4. Myocytes were perfused with 2mM Ca NT with
200mM caffeine in order to increase basal SR Ca leak in the presence of
varying concentrations of tetracaine (1, 10, 30, 100mM). Myocytes were
then rapidly perfused with 0 Na, 0 Ca NT with 1mM tetracaine following
washout with same solution but with varying amounts of tetracaine. SR
Ca leak was quantified as the shift of Ca from the cytosol to the SR upon
blockage of the RyR with high tetracaine. The EC50 for tetracaine is signif-
icantly reduced in intact myocytes compared to single RyR channel. Among
the potential explanations for this effect is the possibility that Ca flux regu-
lation makes the RyR clusters in the SR junction more sensitive to blockage
of release.
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Tetracaine Inhibits RyRs by Three Mechanisms
Derek R. Laver, Dirk F. vanHelden.
Tetracaine is a tertiary amine local anaesthetic (pKa = 8.5) which induces
closures in RyRs. Tetracaine has been extensively used to study the role of
the SR Ca2þ fluxes in Ca2þ handling in muscle cells. We use single channel
recording of rabbit skeletal and sheep cardiac RyRs in lipid bilayers to iden-
tify three mechanisms for tetracaine inhibition. First, luminal and cytoplasmic
tetracaine induce closed events (~100 ms- slow mechanism). Cytoplasmic/lu-
minal competition indicates a common site for cytoplasmic and luminal ac-
tion. The binding rate decreases with increasing RyR open probability,consistent with a closed state mechanism with no detectable binding to
open channels. At pH 7.4, its voltage-dependence points to a cation binding
site within the bilayer, near its luminal interface. At pH 9.5, the slow mech-
anism is independent of voltage, indicating that it also responds to neutral tet-
racaine molecules. Second, cytoplasmic and luminal tetracaine induce brief
closures (~1 ms- fast mechanism). It is insensitive to the open state of the
RyR, independent of voltage and markedly diminished at pH 9.5 indicating
that it is caused exclusively by tetracaine cations binding outside the trans-
membrane electric field. The action of trans-membrane pH gradients on the
fast mechanism points to a cytoplasmic location for the binding site. Finally,
cytoplasmic tetracaine reduces the ionic conductance of the channel at mM
concentrations. We predict that under diastolic conditions, the slow mecha-
nism (IC50 of ~200 mM) is a more potent form of block than the fast mech-
anism or conduction block (IC50 ~ 2mM) and these mechanisms can explain
the differences in the tetracaine inhibition seen at low and high
concentrations.
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Slow Diffusion Across Cell Membrane Delays Onset of RyR2-Channel
Block and Ca Wave Suppression by Flecainide in Intact Myocytes
Hyun Seok Hwang, Eleonora S. Galimberti, Bjorn C. Knollmann.RyR2 channel inhibitors
such as flecainide suppress
Ca waves in myocytes and
effectively prevent ventric-
ular arrhythmias in vivo.
Since the RyR2 channel is
located in an intracellular
organelle, the sarcoplasmic
reticulum, differences in
diffusion rates across the
cell membrane and gaining
access to the RyR2 may contribute to variability of drug action in intact myo-
cytes and in vivo. To test this hypothesis, we compared three RyR2 channel in-
hibitors to suppress Ca waves in permeabilized and intact myocytes: flecainide
(Flec:6mM), R-propafenone (R-prop:6mM) and tetracaine (Tetra:50mM). All
three drugs exhibited rapid onset of action in permeabilized myocytes (Figure).
In intact myocytes, only Tetra exhibited rapid onset of action, whereas Flec and
R-prop exhibited significant lag times of 10 min and 5 min, respectively (Fig-
ure). Flec’s slow onset of action in intact myocytes occurred even though its
potency was higher intact (IC50=2mM) than permeabilized myocytes
(IC50=12mM).
Conclusion: Slow diffusion of RyR2 channel blockers such as flecainide across
intact membranes importantly determines the onset of Ca wave suppression,
which has to be taken into account when evaluating drug efficacy in intact my-
oyctes and in vivo.
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Inhibition of Cardiac Ca2þ Release Channels by Class I Anti Arrhythmic
Drugs as Therapy for Arrhythmia
Divya R. Mehra, Dirk F. vanHelden, Bjorn C. Knollmann, Derek R. Laver.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhyth-
mia resulting from mutations in either the cardiac Ca2þ release channel (RyR2)
or calsequestrin. Flecainide is a class-Ic compound that is highly effective in
suppressing arrhythmia in CPVT patients and a calsequestrin-null mouse model
of CPVT. Its efficacy is a combination of reduced membrane excitability via its
known Naþ channel block and stabilisation of SR Ca2þ release by a recently
discovered RyR2 block. Here we report RyR2 blocking kinetics of other class
I anti arrhythmic drugs.
RyR2 was isolated from sheep and human hearts, incorporated in lipid bilayers
and investigated by single-channel recordings in presence of diastolic Ca2þ
(100 nM cytoplasmic, 0.1 mM luminal). The class 1c drugs, propafenone, fle-
cainide and encainide decreased RyR open times (IC50 = 17.35 1.6, 16.75 4
and 22.55 1.2 ı`M respectively) whereas classes Ia and Ib had no significant
effect up to 50 mM.
Blocking kinetics was also measured in fully activated RyR2 (1 mM Ca2þ, 2
mM ATP). All class I drugs tested caused voltage-dependent induction of sub-
conductance states with similar actions from luminal and cytoplasmic sides.
However, class Ic drugs produced subconductances with longer duration and
lower conductance than classes 1a and 1b. These differences may explain the
different efficacy of these drugs to curb Ca2þ release in diastole and prevent
arrhythmia.
